Prenatal maternal mental health and resilience in the United Kingdom during the SARS-CoV-2 pandemic: a cross- national comparison.

anxiety depression maternal mental health mixed methods pregnancy resilience social support

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2024
Historique:
received: 03 04 2024
accepted: 02 09 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: epublish

Résumé

Prenatal mental health problems are associated with morbidity for the pregnant person, and their infants are at long-term risk for poor health outcomes. We aim to explore how the SARS-CoV-2 pandemic affected the mental health of pregnant people in the United Kingdom (UK), and to further identify resilience factors which may have contributed to varying mental health outcomes. We also aim to examine the quality of antenatal care provided during the pandemic in the UK and to identify potential inadequacies to enhance preparedness for future events. During June-November 2020, we recruited 3666 individuals in the UK for the EPPOCH pregnancy cohort (Maternal mental health during the COVID-19 pandemic: Effect of the Pandemic on Pregnancy Outcomes and Childhood Health). Participants were assessed for depression, anxiety, anger and pregnancy-related anxiety using validated scales. Additionally, physical activity, social support, individualized support and personal coping ability of the respondents were assessed as potential resilience factors. Participants reported high levels of depression (57.05%), anxiety (58.04%) and anger (58.05%). Higher levels of social and individualized support and personal coping ability were associated with lower mental health challenges. Additionally, pregnant individuals in the UK experienced higher depression during the pandemic than that reported in Canada. Finally, qualitative analysis revealed that restrictions for partners and support persons during medical appointments as well as poor public health communication led to increased mental health adversities and hindered ability to make medical decisions. This study revealed increased mental health challenges among pregnant individuals in the UK during the SARS-CoV-2 pandemic. These results highlight the need for reassessing the mental health support measures available to pregnant people in the UK, both during times of crisis and in general.

Identifiants

pubmed: 39391080
doi: 10.3389/fpsyt.2024.1411761
pmc: PMC11466367
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1411761

Informations de copyright

Copyright © 2024 Datye, Smiljanic, Shetti, MacRae-Miller, van Teijlingen, Vinayakarao, Peters, Lebel, Tomfohr-Madsen, Giesbrecht, Khashu and Conrad.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Swarali Datye (S)

Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Neonatology and Pediatric Intensive Care, Faculty of Medicine, University of Augsburg, Augsburg, Germany.

Marko Smiljanic (M)

Institute of Botany and Landscape Ecology, University of Greifswald, Greifswald, Germany.

Rohan Shetti (R)

Faculty of Environment, Julius von Payer Institute for Arctic and Subarctic Research, Jan Evangelista Purkyně University, Ústí nad Labem, Czechia.

Alison MacRae-Miller (A)

Department of Family Medicine, University of British Columbia, Vancouver, BC, Canada.

Edwin van Teijlingen (E)

Centre for Midwifery and Women's Health, Bournemouth University, Bournemouth, United Kingdom.

Latha Vinayakarao (L)

University Hospitals Dorset NHS Foundation Trust, Poole, United Kingdom.

Eva M J Peters (EMJ)

Psychoneuroimmunology Laboratory, Department of Psychosomatic Medicine and Psychotherapy, Justus-Liebig University, Gießen, Germany.
Department of Psychosomatic Medicine and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.

Catherine Lebel (C)

Department of Radiology, University of Calgary, Calgary, AB, Canada.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.

Lianne Tomfohr-Madsen (L)

Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.
Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
Department of Psychology, University of Calgary, Calgary, AB, Canada.

Gerald Giesbrecht (G)

Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada.
Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
Department of Psychology, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Minesh Khashu (M)

University Hospitals Dorset NHS Foundation Trust, Poole, United Kingdom.

Melanie L Conrad (ML)

Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Neonatology and Pediatric Intensive Care, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Institute for Medical Psychology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

Classifications MeSH